v3.25.4
Collaboration and other arrangements (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Significant agreements          
Research and development $ 53,140,000 $ 48,004,000 $ 168,860,000 $ 135,472,000  
Prepaid expenses and other current assets 8,262,000   $ 8,262,000   $ 8,351,000
Roche          
Significant agreements          
Termination period     60 days    
Prepaid expenses and other current assets 0   $ 0   $ 0
Roche | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Significant agreements          
Research and development 0 0 0 0  
Proceeds from collaborators $ 0.0 $ 1,800,000 $ 0.0 $ 1,800,000